Rodman & Renshaw (RODM) Sees Insider Buying
More News related to RODM
- Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option
- Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share
- Skystar Bio-Pharmaceutical Announces Pricing of Public Offering of Common Stock
- Skystar Bio-Pharmaceutical (SKBI) Prices 1.4M Shares At $12.98 A Share
- Rodman & Renshaw Capital Group, Inc. Schedules Conference Call to Discuss Preliminary Financial Results for the Second Quarter of 2009
Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) sees insider buying. After the close, CEO Michael Lacovara disclosed a purchase of 50,000 shares on 11/17 at $1.12 and today CFO David Horin disclosed a purchase of 11,695 shares on 11/17 at $1.18.
Shares of Rodman & Renshaw are up 3.6% today to $1.15, with a 52-week range of $0.59-$4.45.
Rodman & Renshaw Capital Group, Inc., through its subsidiaries, engages in investment banking business.
Related Categories
Insider TradesStocks Mentioned
-0.04Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
